Skip to content

Comparison of Ultrasound-Guided Median nerve Hydrodissection with Corticosteroid Injection in the treatment of mild to moderate Carpal Tunnel Syndrome

Comparison of Ultrasound-Guided Median nerve Hydrodissection with Corticosteroid Injection in the treatment of mild to moderate Carpal Tunnel Syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210613051566N1
Enrollment
60
Registered
2021-12-17
Start date
2021-12-22
Completion date
Unknown
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal tunnel syndrome. Carpal tunnel syndrome

Interventions

Intervention 1: Intervention group: Patients in this group will undergo a Ultrasound-guided Median nerve hydrodissection with corticosteroid injection. Total of 5cc solution consisting of 1cc of Triam

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Confirmed clinical and Electrophysiological diagnosis of Carpal Tunnel Syndrome with mild to moderate degree

Exclusion criteria

Exclusion criteria: Confirmed clinical and Electrophysiological diagnosis of CTS with severe degree Patients with suspicious of CTS mimic condition, including cervical radiculopathy, polyneuropathy, brachial plexopathy, thoracic outlet syndrome Recent corticosteroid injection to the carpal tunnel within 6 months Previous history of carpal tunnel surgical release Steroid injection contraindications Pregnancy Cancer Coagulopathy

Design outcomes

Primary

MeasureTime frame
Boston carpal tunnel syndrome questionnaire (BCTQ). Timepoint: Pre-treatment, 1st, 3rd and 6th months after injection. Method of measurement: five-point rating scale questionnaire.

Secondary

MeasureTime frame
Visual Analog Scale (VAS) for Pain. Timepoint: Pre injection, 2 weeks, 1, 3 and 6 months intervals. Method of measurement: Visual and numeric scale.;Cross-sectional area of the Median nerve. Timepoint: Pre injection, 1, 3 and 6 months intervals. Method of measurement: Ultrasound device.;Conduction Velocity, Distal Latency and Amplitude of Median nerve SNAP & CMAP. Timepoint: Pre injection, 1, 3 and 6 months intervals. Method of measurement: EMG- NCV.;Hand grip strength. Timepoint: Pre injection, 1, 3 and 6 months intervals. Method of measurement: Dynamometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSahar Ghorbanpour

Tehran University of Medical Sciences

sahar.ghorbanpour@gmail.com+98 21 8870 1551

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026